EFFICACY OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR WITH ZINC AND CHROMIUM PICOLINATE IN PATIENTS OF TYPE-II DIABETES MELLITUS

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2016, Vol 5, Issue 5

Abstract

In the present study, we have evaluated the effect of Zinc (Zn) and Chromium picolinate (CrPic) supplementation with sitagliptin in Type-II DM patients. A randomized controlled trial was conducted on 600 patients suffering from Type-II DM. Patients from four different hospitals of Punjab were divided into three groups comprising of 200 patients each. Group A was given sitagliptin (100mg), group B received Zn sulphate (10mg) for 12 weeks along with sitagliptin and group C received CrPic (200mcg) along with sitagliptin. Blood samples of the patients were collected before starting the treatment (zero time sample) and then after 12 weeks of the treatment, to monitor the changes in different study parameters. Blood sugar fasting (BSF) and Glycated hemoglobin (HbA1c) was measured by ion exchange chromatography by using a commercial kit (Sigma-Aldrich, St Louis, MO, USA). Analysis of variance (ANOVA) was used to compare the efficacy of all treatment groups. P value ≤ 0.05 was considered significant. Results indicated that all defined therapies have insignificant influence with respect to gender as p = 1.000. BSF and HbA1c in group B was found effective in all treatments at all levels of study with p=0.000. Our study concludes that Zn supplementation with sitagliptin on glycemic control in patients with Type-II DM gave the best treatment option. Keywords: BSF, CrPic, HbA1C, Type-II DM, Zinc

Authors and Affiliations

TANVEER AHMED KHAN

Keywords

Related Articles

Gene expression and sequencing techniques of transcriptome to elucidate novel function for phospholipase (s) enzyme

Sequencing of RNA, or RNA-Seq, is now a common method to analyze gene expression and to uncover novel RNA species. Aspects of RNA biogenesis and metabolism can be evaluated with specialized methods for cDNA library prepa...

FORMULATION AND EVALUATION OF FAST DISSOLVING ORAL FILMS OF FLUVASTATIN SODIUM BY USING TASTE MASKING TECHNIQUES

Fluvastatin sodium, a HMG-COA reductase inhibitor has shorter half life (1.2). It undergoes extensive first pass metabolism, frequent dosing is required in case of conventional dosage form. It is an bitter drug so an att...

Spherical Crystallization: A Novel Particle Design Technique

Oral route is the most important route of drug administration. In this route, the solid dosage form specially tablets, are the first choice of patient but due to unfavorable physical and mechanical properties their formu...

Self-medication and role of pharmacist in patient education

Introduction: Pharmacy is the art, science and practice of preparing, preserving, compounding and dispensing of drugs and it also includes modern services related to health care including clinical services, reviewing med...

INFLUENCE OF NON SURGICAL THERAPY ON SERUM ALBUMIN AND WBC COUNT IN DIABETIC AND NON DIABETICS WITH CHRONIC PERIODONTITIS

BACKGROUND: Periodontal disease is a complex, multifactorial, chronic inflammatory disease that involves destruction of Periodontium. Many systemic diseases have been implicated as risk factors or risk indicators in peri...

Download PDF file
  • EP ID EP418349
  • DOI -
  • Views 117
  • Downloads 0

How To Cite

TANVEER AHMED KHAN (2016). EFFICACY OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR WITH ZINC AND CHROMIUM PICOLINATE IN PATIENTS OF TYPE-II DIABETES MELLITUS. Journal of Biomedical and Pharmaceutical Research, 5(5), 65-71. https://europub.co.uk/articles/-A-418349